Skip to search formSkip to main contentSkip to account menu

Opiren

Known as: Almirall Brand of Lansoprazole, Lansoprazole Almirall Brand 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

lansoprazole

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Sarecycline: First Global Approval
Sarecycline (Seysara™) is an oral, once-daily, tetracycline-class drug for which a tablet formulation is approved in the USA for… 
2017
2017
The effectiveness of using a bath oil to reduce signs of dry skin: A randomized controlled pragmatic study.
Highly Cited
2016
Highly Cited
2016
Management of side effects of immune checkpoint blockade by anti‐CTLA‐4 and anti‐PD‐1 antibodies in metastatic melanoma
CTLA‐4 and PD‐1 are potential targets for tumor‐induced downregulation of lymphocytic immune responses. Immune checkpoint… 
2014
2014
Methylisothiazolinone: second ‘epidemic’ of isothiazolinone sensitization
Isothiazolinones are used as biocides in a wide variety of products, such as cosmetics, detergents, and industrial products. In… 
2014
2014
Cortical Ischemic Lesion Burden Measured by DIR Is Related to Carotid Artery Disease Severity
Background: Over time, exposure to cerebrovascular risk factors and carotid artery disease may cause multiple asymptomatic brain… 
2013
2013
Monitoring contact sensitization to p‐phenylenediamine (PPD) by patch testing with PPD 0.3% in petrolatum
Being a contact allergen of general relevance, p‐phenylenediamine (PPD) is patch tested in the baseline series. However, PPD 1… 
Review
2013
Review
2013
Aclidinium Bromide Twice Daily for the Treatment of Chronic Obstructive Pulmonary Disease: A Review
The inhaled, long-acting muscarinic antagonist, aclidinium bromide, was indicated in July 2012 in Europe and the USA for the… 
2012
2012
Cutaneous pseudolymphoma induced by adalimumab and reproduced by infliximab in a patient with arthropathic psoriasis
pet., palladium chloride 1% pet., ammonium tetrachloroplatinate 0Æ15% pet. and ammoniated mercury 1% pet.) and the dental… 
Review
2010
Review
2010
A2B receptor ligands: past, present and future trends.
A(2B) adenosine receptors have been investigated in recent years as potential target for the treatment of different pathologies… 
Review
2009
Review
2009
Aclidinium bromide, a novel long-acting muscarinic M3 antagonist for the treatment of COPD.
Aclidinium bromide is a novel, inhaled, long-acting antimuscarinic agent being developed by Almirall Prodesfarma SA and Forest… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)